Scientific Sessions 2025  /  Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH  /  Heterogeneity Among Preclinical Models of Group 2 or Group 3 PH: Myth or Reality?
Logo

American Heart Association

  31
  0

Final ID:

Heterogeneity Among Preclinical Models of Group 2 or Group 3 PH: Myth or Reality?

  • Lai, Yen Chun  ( Indiana University , Indianapolis , Indiana , United States )
  • Shimoda, Larissa  ( JOHNS HOPKINS SCHOOL OF MEDICINE , Baltimore , Maryland , United States )
  • Goncharova, Elena  ( University of California, Davis , Davis , California , United States )
    • Author Disclosures:
    Yen Chun Lai: DO NOT have relevant financial relationships | Larissa Shimoda: No Answer | Elena Goncharova: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH

Monday, 11/10/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Molecular Determinants of Vascular Remodeling in Group 3 PH

Karmouty-quintana Harry, Eghbali Mansoureh, Ruffenach Gregoire

Combined Pre- and Post-Capillary PH: What Models Do We Use to Study the Disease?

Agrawal Vineet, Brittain Evan, Maron Brad

More abstracts from these authors:
NHE1 Regulates Apoptosis Susceptibility in Sugen-Hypoxia Pulmonary Arterial Smooth Muscle Cells via Modulation of CHOP

Ribas Andrade Manuella, Yun Xin, Shimoda Larissa

Epigenetic Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Hypertension

Hadri Lahouaria, Stenmark Kurt, Goncharova Elena, Bonnet Sebastien

You have to be authorized to contact abstract author. Please, Login
Not Available